4.29
price up icon3.37%   0.14
pre-market  Vorhandelsmarkt:  4.35   0.06   +1.40%
loading
Schlusskurs vom Vortag:
$4.15
Offen:
$4.13
24-Stunden-Volumen:
2.00M
Relative Volume:
1.00
Marktkapitalisierung:
$1.30B
Einnahmen:
$248.37M
Nettoeinkommen (Verlust:
$11.74M
KGV:
85.80
EPS:
0.05
Netto-Cashflow:
$18.24M
1W Leistung:
+4.13%
1M Leistung:
-14.20%
6M Leistung:
-34.90%
1J Leistung:
-8.14%
1-Tages-Spanne:
Value
$4.13
$4.35
1-Wochen-Bereich:
Value
$4.07
$4.35
52-Wochen-Spanne:
Value
$4.05
$7.63

Mannkind Corp Stock (MNKD) Company Profile

Name
Firmenname
Mannkind Corp
Name
Telefon
818-661-5000
Name
Adresse
1 CASPER STREET, DANBURY, CA
Name
Mitarbeiter
407
Name
Twitter
@MannKindCorp
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
MNKD's Discussions on Twitter

Vergleichen Sie MNKD mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
MNKD
Mannkind Corp
4.29 1.28B 248.37M 11.74M 18.24M 0.05
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.93 25.76B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.43 114.53B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.415 40.54M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
84.10 6.44B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.81 65.13B 14.09B 4.50B 2.96B 39.28

Mannkind Corp Stock (MNKD) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-10 Eingeleitet Mizuho Outperform
2025-02-10 Eingeleitet Wedbush Outperform
2024-12-20 Eingeleitet Wells Fargo Overweight
2024-12-19 Hochstufung RBC Capital Mkts Sector Perform → Outperform
2024-09-09 Fortgesetzt Leerink Partners Outperform
2024-06-13 Eingeleitet Rodman & Renshaw Buy
2023-10-10 Eingeleitet Wedbush Outperform
2021-05-14 Eingeleitet RBC Capital Mkts Sector Perform
2019-12-24 Eingeleitet Oppenheimer Outperform
2019-10-25 Eingeleitet Cantor Fitzgerald Overweight
2019-05-14 Eingeleitet BTIG Research Buy
2019-03-04 Eingeleitet SVB Leerink Outperform
2019-02-22 Eingeleitet SVB Leerink Outperform
2018-02-28 Herabstufung Maxim Group Hold → Sell
2017-11-01 Herabstufung Maxim Group Buy → Hold
2017-10-10 Eingeleitet H.C. Wainwright Buy
2017-10-06 Bestätigt Maxim Group Buy
2017-08-11 Eingeleitet Maxim Group Buy
2016-05-10 Bestätigt Piper Jaffray Underweight
2016-05-10 Bestätigt RBC Capital Mkts Underperform
2016-01-06 Bestätigt Piper Jaffray Underweight
2016-01-06 Bestätigt RBC Capital Mkts Underperform
2015-11-04 Herabstufung RBC Capital Mkts Outperform → Underperform
2015-09-09 Herabstufung Piper Jaffray Neutral → Underweight
2015-08-03 Bestätigt RBC Capital Mkts Outperform
2015-05-11 Herabstufung JP Morgan Neutral → Underweight
2015-05-11 Bestätigt MLV & Co Hold
2015-04-16 Bestätigt RBC Capital Mkts Outperform
Alle ansehen

Mannkind Corp Aktie (MNKD) Neueste Nachrichten

pulisher
May 27, 2025

MannKind: Why I'm Still Bullish Despite Tyvaso DPI Competition - Seeking Alpha

May 27, 2025
pulisher
May 20, 2025

MannKind stock touches 52-week low at $4.34 amid market shifts - Investing.com Canada

May 20, 2025
pulisher
May 20, 2025

MannKind at RBC Conference: Strategic Growth and Innovation By Investing.com - Investing.com Canada

May 20, 2025
pulisher
May 20, 2025

MannKind at RBC Conference: Strategic Growth and Innovation - Investing.com

May 20, 2025
pulisher
May 20, 2025

MannKind To Present At RBC Capital Markets Conference; Webcast At 8:00 AM ET - Nasdaq

May 20, 2025
pulisher
May 16, 2025

Most adults with type 1 diabetes using inhaled insulin increase daily dose over 30 weeks - Healio

May 16, 2025
pulisher
May 15, 2025

MannKind corp director Steven Binder sells $375,875 in stock By Investing.com - Investing.com Nigeria

May 15, 2025
pulisher
May 15, 2025

MannKind EVP David Thomson sells shares worth $150,597 By Investing.com - Investing.com India

May 15, 2025
pulisher
May 15, 2025

MannKind EVP David Thomson sells shares worth $150,597 - Investing.com

May 15, 2025
pulisher
May 15, 2025

MannKind corp director Steven Binder sells $375,875 in stock - Investing.com

May 15, 2025
pulisher
May 15, 2025

MannKind CMO steps down, transition plan set - Investing.com

May 15, 2025
pulisher
May 13, 2025

MannKind to Present at Upcoming Investor Conferences - The Globe and Mail

May 13, 2025
pulisher
May 11, 2025

MannKind Corporation (NASDAQ:MNKD) Q1 2025 Earnings Call Transcript - Insider Monkey

May 11, 2025
pulisher
May 09, 2025

MannKind Corporation (MNKD): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Insider Monkey

May 09, 2025
pulisher
May 09, 2025

Decoding MannKind Corp (MNKD): A Strategic SWOT Insight - GuruFocus

May 09, 2025
pulisher
May 08, 2025

10 Best Cancer Stocks to Invest in for Long-Term Gains - Insider Monkey

May 08, 2025
pulisher
May 08, 2025

MannKind: Q1 Earnings Snapshot - MySA

May 08, 2025
pulisher
May 08, 2025

Earnings call transcript: MannKind Q1 2025 revenue beats, stock dips - Investing.com

May 08, 2025
pulisher
May 08, 2025

MannKind (MNKD) Surpasses Q1 Revenue Expectations with Strong Gr - GuruFocus

May 08, 2025
pulisher
May 08, 2025

MannKind (MNKD) Surpasses Q1 Revenue Expectations with Strong Growth | MNKD Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

MannKind Corp Q1 2025 Earnings: EPS Meets Estimates at $0.04, Revenue Surpasses Expectations at $78 Million - GuruFocus

May 08, 2025
pulisher
May 08, 2025

MannKind Corporation Reports First Quarter 2025 Financial Results - TradingView

May 08, 2025
pulisher
May 08, 2025

MANNKIND CORP SEC 10-Q Report - TradingView

May 08, 2025
pulisher
May 08, 2025

MannKind Corporation Reports First Quarter 2025 Financial Results and Provides Business Update - Yahoo Finance

May 08, 2025
pulisher
May 07, 2025

MannKind Corp (MNKD) Q1 2025 Earnings Report Preview: What To Ex - GuruFocus

May 07, 2025
pulisher
May 07, 2025

MannKind Corp (MNKD) Q1 2025 Earnings Report Preview: What To Expect - Yahoo Finance

May 07, 2025
pulisher
May 01, 2025

MannKind Corporation to Hold 2025 First Quarter Financial Results Conference Call on May 8, 2025 - The Globe and Mail

May 01, 2025
pulisher
Apr 29, 2025

The Potential Rise in the Price of Mannkind Corp (MNKD) following insiders activity - knoxdaily.com

Apr 29, 2025
pulisher
Apr 29, 2025

Solidion Technology Inc’s latest rating changes from various analysts - knoxdaily.com

Apr 29, 2025
pulisher
Apr 23, 2025

MNKD (Mannkind Corp) may reap gains as insiders became active recently - knoxdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

Mannkind Corp (MNKD) is looking forward to a strong quarter - Sete News

Apr 23, 2025
pulisher
Apr 18, 2025

Is MannKind Corporation (MNKD) the Best Quality Penny Stock to Buy According to Hedge Funds? (READY TO EDIT2) - Insider Monkey

Apr 18, 2025
pulisher
Apr 16, 2025

Is MannKind Corp. (NASDAQ:MNKD) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Insider Monkey

Apr 16, 2025
pulisher
Apr 15, 2025

13 Best Biotech Penny Stocks to Buy According to Hedge Funds - Insider Monkey

Apr 15, 2025
pulisher
Apr 12, 2025

MannKind (NASDAQ:MNKD) Upgraded at Mizuho - Defense World

Apr 12, 2025
pulisher
Apr 10, 2025

This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Apr 10, 2025
pulisher
Apr 09, 2025

Mizuho sets MannKind stock Outperform with $12 target - Investing.com

Apr 09, 2025
pulisher
Apr 09, 2025

Mizuho sets MannKind stock Outperform with $12 target By Investing.com - Investing.com India

Apr 09, 2025
pulisher
Apr 07, 2025

Diabetes Meets Racing: MannKind's Game-Changing Partnership With Type 1 Diabetic IndyCar Star - Stock Titan

Apr 07, 2025
pulisher
Apr 07, 2025

MannKind To Support Conor Daly - Speed Sport

Apr 07, 2025
pulisher
Apr 07, 2025

MannKind Teams Up with Juncos Hollinger Racing (JHR) Driver Conor Daly to Drive Awareness of Diabetes and Innovative Treatment Options - Yahoo Finance

Apr 07, 2025
pulisher
Mar 28, 2025

FTNT Stock Sees Surge of Approximately 1.11% in Last Five Days - knoxdaily.com

Mar 28, 2025
pulisher
Mar 25, 2025

Why It's Worth Keeping An Eye On MannKind - RTTNews

Mar 25, 2025
pulisher
Mar 21, 2025

Cantor maintains Overweight rating on MannKind stock at $9 target - Investing.com

Mar 21, 2025

Finanzdaten der Mannkind Corp-Aktie (MNKD)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$1.15
price up icon 6.48%
$31.19
price up icon 3.48%
$584.61
price up icon 1.98%
$306.09
price up icon 0.50%
$4.5994
price up icon 2.21%
$490.81
price up icon 0.11%
Kapitalisierung:     |  Volumen (24h):